SUZHOU, China, March 29, 2023 /PRNewswire/ — Medical technology company Scivita Medical Technology Co., Ltd. (‘Scivita Medical’) and Boston Scientific (NYSE: BSX), a leading medical technology company have officially signed a strategic agreement for Scivita’s single-use percutaneous choledochoscope. Through this business cooperation and distribution agreement, Scivita Medical and Boston Scientific plan to establish a long-term partnership for the commercialization, marketing, and promotion of Scivita’s single-use percutaneous choledochoscope in China.
Leveraging Scivita Medical’s wide product range, including reusable endoscopes, single-use videoscopes, and related systems and equipment, this cooperation further expands the market penetration of its single-use percutaneous choledochoscope. Through the strong partnership with Boston Scientific, the penetration rate of the single-use percutaneous choledochoscope in China is expected to increase, benefiting more hospitals and patients.
Scivita Medical said, ‘Thank you to Boston Scientific for their recognition of Scivita Medical. This is another important initiative for Scivita Medical in establishing its vision to become a global company, and another milestone following its strategic cooperation with Fujifilm for the European market. I believe this strategic cooperation with some of the world’s leading medtech companies and our company will speed up the process of bringing China’s medical innovations to the world.’
As a result of the increasing demand to mitigate the risks of cross-contamination and hospital-acquired diseases, particularly amid the outbreak of the COVID-19 pandemic, the global market for single-use videoscopes is also growing rapidly. According to Frost
This cooperation can be considered as a testament to Scivita Medical’s comprehensive product range of reusable endoscopes, single-use videoscopes, and related systems and equipment, further accelerating its commercialization and penetration into the field of single-use videoscopes. Going forward, Scivita Medical will further strengthen its innovation, enhance market penetration by offering unique products, and strive to become the preferred brand of doctors and patients around the world.
About Scivita Medical
Founded in 2016, Scivita Medical is a medical device company that provides minimally invasive diagnostic and treatment solutions, focusing on the research, development, and commercialization of medical endoscopes and related products. Scivita Medical takes ‘Globalization’ as its core strategy and has established R&D centers in both China and Japan. With strong in-house R&D capabilities, Scivita Medical has established a unique technology platform based on five synergistic core technologies, and has created a complete portfolio of endoscopic and therapeutic products covering all types of endoscopic procedures performed by the various clinical departments, to address various medical needs. Adhering to its value of “Clinical Focus”, “Collaborative Innovation”, “People Orientation”, “Excellence and Efficiency”, Scivita Medical will continuously upgrade its core technologies, enhance market penetration with excellent products with the aim of becoming the preferred brand, trusted by doctors and patients around the world.
For more information, visit: scivitamedical.com/
Photo – https://mma.prnewswire.com/media/2043103…Photo – https://mma.prnewswire.com/media/2043104…Photo – https://mma.prnewswire.com/media/ 2043105…
View original content: https://www.prnewswire.com/news-releases/scivita-medical-firma-un-acuerdo-estrategico-con-boston-scientific-en-china-301784793.html
